Latest Research On GLP-1 And Its Future In Healthcare
Until recently, glucagon-like peptide-1 (GLP-1) receptor agonists were known primarily as a treatment for type 2 diabetes. But today, these drugs have transformed into a major player in weight loss therapy. Moreover, they are on the verge of reshaping the entire healthcare landscape. From treating obesity to possibly impacting neurodegenerative diseases and addiction disorders, the … Read more